Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Liuxiang Chu, Aiping Wang, Ling Ni, Xiuju Yan, Yina Song, Mingyu Zhao, Kaoxiang Sun, Hongjie Mu, Sha Liu, Zimei Wu & Chunyan Zhang. (2018) Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting. Drug Delivery 25:1, pages 1634-1641.
Read now
Read now
Raffaele Addeo, Silvia Zappavigna, Amalia Luce, Sergio Facchini & Michele Caraglia. (2013) Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. Expert Opinion on Drug Safety 12:5, pages 729-740.
Read now
Read now
Alexander Faje & Lisa Nachtigall. (2013) Current treatment options for hyperprolactinemia. Expert Opinion on Pharmacotherapy 14:12, pages 1611-1625.
Read now
Read now
Trine Zeeberg Iversen, Marie Klinge Brimnes, Kirsten Nikolajsen, Rikke Sick Andersen, Sine Reker Hadrup, Mads Hald Andersen, Lars Bastholt & Inge Marie Svane. (2013) Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients. OncoImmunology 2:2.
Read now
Read now
Xin-Hua Tian, Xiao-Ning Lin, Feng Wei, Wei Feng, Zhi-Chun Huang, Peng Wang, Lei Ren & Yi Diao. (2011) Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. International Journal of Nanomedicine 6, pages 445-452.
Read now
Read now
Articles from other publishers (55)
Emir Begagić, Ragib Pugonja, Hakija Bečulić, Amila Čeliković, Lejla Tandir Lihić, Samra Kadić Vukas, Lejla Čejvan, Rasim Skomorac, Edin Selimović, Belma Jaganjac, Fatima Juković-Bihorac, Aldin Jusić & Mirza Pojskić. (2023) Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings. Brain Sciences 13:11, pages 1602.
Crossref
Crossref
Ruixuan Wang, Yanhong Chen, Weilu Kuang, Wuzhong Jiang, Wenjing Zeng, Yinyun Chen & Zhengzheng Liu. (2023) Valproic acid regulates the miR-155/Jarid2 axis by affecting miR-155 promoter methylation in glioma. Acta Biochimica et Biophysica Sinica.
Crossref
Crossref
Priyanka Verma, Hemant Joshi, Tejveer Singh, Bunty Sharma, Ujjawal Sharma, Seema Ramniwas, Rashmi Rana, Madhu Gupta, Ginpreet Kaur & Hardeep Singh Tuli. (2023) Temozolomide and flavonoids against glioma: from absorption and metabolism to exosomal delivery. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Crossref
Nicolly Espindola Gelsleichter, Priscila Oliveira de Souza, Fernanda Cardoso Teixeira, Gabriela Nogueira Debom, Gabriela Spies Lenz, Gabriela Gonçalves Roliano, Rita de Cássia Sant’ana, Fernanda Visioli, Flávia Nathiely Silveira Fachel, Luana Roberta Michels, Juliana Hofstätter Azambuja, Helder Ferreira Teixeira & Elizandra Braganhol. (2023) Metastatic Melanoma: A Preclinical Model Standardization and Development of a Chitosan-Coated Nanoemulsion Containing Temozolomide to Treat Brain Metastasis. Cellular and Molecular Neurobiology 43:6, pages 2939-2951.
Crossref
Crossref
Sho Tamai, Toshiya Ichinose, Shabierjiang Jiapaer, Nozomi Hirai, Hemragul Sabit, Shingo Tanaka, Masashi Kinoshita, Masahiko Kobayashi, Atsushi Hirao & Mitsutoshi Nakada. (2023) Therapeutic potential of pentamidine for glioma‐initiating cells and glioma cells through multimodal antitumor effects. Cancer Science 114:7, pages 2920-2930.
Crossref
Crossref
Salomé Araujo-Abad, Antonio Manresa-Manresa, Enrique Rodríguez-Cañas, María Fuentes- Baile, Pilar García-Morales, Ricardo Mallavia, Miguel Saceda & Camino de Juan Romero. (2023) New therapy for pancreatic cancer based on extracellular vesicles. Biomedicine & Pharmacotherapy 162, pages 114657.
Crossref
Crossref
Daniel Ruiz-Molina, Xiaoman Mao, Paula Alfonso-Triguero, Julia Lorenzo, Jordi Bruna, Victor J. Yuste, Ana Paula Candiota & Fernando Novio. (2022) Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?. Cancers 14:19, pages 4960.
Crossref
Crossref
Puja Sandbhor, Jayant. S. Goda, Bhabani Mohanty, Pradip Chaudhari, Shilpee Dutt & Rinti Banerjee. (2022) Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy. Nanoscale 14:35, pages 12773-12788.
Crossref
Crossref
Tong Wang, Qian Meng, Lan Lin, Li Yang, Wenjiao Zhao & Dequn Sun. (2022) Self-assembled dehydropeptide nanocarrier as a delivery system for antitumor drug temozolomide. Bioorganic Chemistry 124, pages 105842.
Crossref
Crossref
Qi Lin, Jia-Hao Bao, Fei Xue, Jia-Jun Qin, Zhen Chen, Zhong-Rong Chen, Chao Li, Yi-Xuan Yan, Jin Fu, Zhao-Li Shen & Xian-Zhen Chen. (2022) The Risk of Heart Disease-Related Death Among Anaplastic Astrocytoma Patients After Chemotherapy: A SEER Population-Based Analysis. Frontiers in Oncology 12.
Crossref
Crossref
Eno I. Essien, Thomas P. Hofer, Michael J. Atkinson & Nataša Anastasov. (2022) Combining HDAC and MEK Inhibitors with Radiation against Glioblastoma-Derived Spheres. Cells 11:5, pages 775.
Crossref
Crossref
Xiaoman Mao, Shuang Wu, Pilar Calero-Pérez, Ana P. Candiota, Paula Alfonso, Jordi Bruna, Victor J. Yuste, Julia Lorenzo, Fernando Novio & Daniel Ruiz-Molina. (2022) Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment. Cancers 14:2, pages 410.
Crossref
Crossref
Catherine R. Garcia, Zin W. Myint, Rani Jayswal, Chi Wang, Rachael M. Morgan, Allison R. Butts, Heidi L. Weiss & John L. Villano. (2021) Hematological adverse events in the management of glioblastoma. Journal of Neuro-Oncology 156:1, pages 153-161.
Crossref
Crossref
Vahid Heravi Shargh, Jeni Luckett, Kaouthar Bouzinab, Stephen Paisey, Lyudmila Turyanska, William G. B. Singleton, Stephen Lowis, Pavel Gershkovich, Tracey D. Bradshaw, Malcolm F. G. Stevens, Alison Bienemann & Beth Coyle. (2021) Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue. ACS Applied Materials & Interfaces 13:30, pages 35266-35280.
Crossref
Crossref
Masoumeh Bayanati, Abolfazl Ghafouri Khosroshahi, Maryam Alvandi & Mohammad Mehdi Mahboobian. (2021) Fabrication of a Thermosensitive In Situ Gel Nanoemulsion for Nose to Brain Delivery of Temozolomide. Journal of Nanomaterials 2021, pages 1-11.
Crossref
Crossref
Tatyana Alexandrovna Bogoyavlenskaya, Ekaterina Evgenyevna Tyagunova, Roman Konstantinovich Kostin, Alexander Sergeevich Zaharov, Yuriy Leonidovich Vasil'ev & Olesya Vasilevna Kytko. (2021) Glioblastoma Break-in; Try Something New. International Journal of Cancer Management 14:1.
Crossref
Crossref
Weiwei Ji & Zhilan Liu. (2021) Temozolomide-Loaded Solid Lipid Nanoparticles@Hydrogel for Local Treatment of Tumour. Australian Journal of Chemistry 74:2, pages 125.
Crossref
Crossref
Vishnu S. Mishra, Naveen Kumar, Masoom Raza & Seema Sehrawat. (2020) Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme. Oncotarget 11:51, pages 4754-4769.
Crossref
Crossref
Tiphaine Obara, Marie Blonski, Cyril Brzenczek, Sophie Mézières, Yann Gaudeau, Celso Pouget, Guillaume Gauchotte, Antoine Verger, Guillaume Vogin, Jean-Marie Moureaux, Hugues Duffau, Fabien Rech & Luc Taillandier. (2020) Adult Diffuse Low-Grade Gliomas: 35-Year Experience at the Nancy France Neurooncology Unit. Frontiers in Oncology 10.
Crossref
Crossref
Muhammad Younis, Wang Faming, Zhao Hongyan, Tan Mengmeng, Song Hang & Yuan Liudi. (2019) Iguratimod encapsulated PLGA-NPs improves therapeutic outcome in glioma, glioma stem-like cells and temozolomide resistant glioma cells. Nanomedicine: Nanotechnology, Biology and Medicine 22, pages 102101.
Crossref
Crossref
Luana R. Michels, Flávia N.S. Fachel, Juliana H. Azambuja, Nicolly E. Gelsleichter, Elizandra Braganhol & Helder F. Teixeira. (2019)
HPLC–UV method for temozolomide determination in complex biological matrices: Application for
in vitro
,
ex vivo
and
in vivo
studies
. Biomedical Chromatography 33:10.
Crossref
Crossref
Shiyuan Anabeth Liu, Timothy Sullivan, Clare Bryce, Amy M Chan & Salvatore Cilmi. (2019) Cerebral aspergillosis within new tumour site presents as incidental new brain lesion in patient receiving temozolomide for glioblastoma multiforme. BMJ Case Reports 12:5, pages e227500.
Crossref
Crossref
Alexander Faje, Marcus A. Zachariah & Brooke Swearingen. 2019. Prolactin Disorders. Prolactin Disorders
137
159
.
Anam Khan, Mohd. Aqil, Syed Sarim Imam, Abdul Ahad, Yasmin Sultana, Asgar Ali & Khalid Khan. (2018) Temozolomide loaded nano lipid based chitosan hydrogel for nose to brain delivery: Characterization, nasal absorption, histopathology and cell line study. International Journal of Biological Macromolecules 116, pages 1260-1267.
Crossref
Crossref
Ru-Bing Wang, Hai-Ning Lv, Shan-Shan Zhu, Xiao-Dong Ren, Song Xu, Shuang-Gang Ma, Yun-Bao Liu, Jing Qu & Shi-Shan Yu. (2018) A novel and practical synthesis of CAT3: a phenanthroindolizidine alkaloid with potential in treating glioblastoma. RSC Advances 8:51, pages 29301-29308.
Crossref
Crossref
Kaidi Li, Naixin Liang, Huaxia Yang, Hongsheng Liu & Shanqing Li. (2017)
Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both
in vitro
and
in vivo
. Oncotarget 8:67, pages 111318-111332.
Crossref
Crossref
Clark Zhang, Elizabeth A. Nance, Panagiotis Mastorakos, Jane Chisholm, Sneha Berry, Charles Eberhart, Betty Tyler, Henry Brem, Jung Soo Suk & Justin Hanes. (2017) Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats. Journal of Controlled Release 263, pages 112-119.
Crossref
Crossref
Yu-Jie Liu, Ying-Cong Ma, Wen-Jie Zhang, Zhen-Zhen Yang, De-Sheng Liang, Zhi-Fu Wu & Xian-Rong Qi. (2017) Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation. Oncotarget 8:26, pages 42495-42509.
Crossref
Crossref
Marc Dahlmanns, Eduard Yakubov, Daishi Chen, Tina Sehm, Manfred Rauh, Nicolai Savaskan & Jana Katharina Wrosch. (2017) Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool. Cell Death Discovery 3:1.
Crossref
Crossref
Birgitta I. Hiddinga, Patrick Pauwels, Annelies Janssens & Jan P. van Meerbeeck. (2017) O 6 -Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?. Lung Cancer 107, pages 91-99.
Crossref
Crossref
K.A. Riccione, P. Gedeon, L. Sanchez-Perez & J.H. Sampson. 2017. Translational Immunotherapy of Brain Tumors. Translational Immunotherapy of Brain Tumors
261
300
.
Anam Khan, Syed Sarim Imam, Mohammed Aqil, Abdul Ahad, Yasmin Sultana, Asgar Ali & Khalid Khan. (2016) Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses. Molecular Pharmaceutics 13:11, pages 3773-3782.
Crossref
Crossref
Ju Chen, Haining Lv, Jinping Hu, Ming Ji, Nina Xue, Chao Li, Shuanggang Ma, Qin Zhou, Bin Lin, Yan Li, Shishan Yu & Xiaoguang Chen. (2016) CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway. Cancer Letters 381:2, pages 391-403.
Crossref
Crossref
Antonio Di Martino, Alena Pavelkova, Sandra Maciulyte, Saulute Budriene & Vladimir Sedlarik. (2016) Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide. European Journal of Pharmaceutical Sciences 92, pages 276-286.
Crossref
Crossref
L.Burt Nabors, Birgit Surboeck & Wolfgang Grisold. 2016. Gliomas. Gliomas
235
250
.
Giuseppe Lombardi, Enrica Rumiato, Roberta Bertorelle, Daniela Saggioro, Patrizia Farina, Alessandro Della Puppa, Fable Zustovich, Franco Berti, Valeria Sacchetto, Raffaella Marcato, Alberto Amadori & Vittorina Zagonel. (2015) Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment. American Journal of Clinical Oncology 38:5, pages 514-519.
Crossref
Crossref
RÉMI ROSIÈRE, MICHEL GELBCKE, VÉRONIQUE MATHIEU, PIERRE VAN ANTWERPEN, KARIM AMIGHI & NATHALIE WAUTHOZ. (2015) New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy. International Journal of Oncology 47:3, pages 1131-1142.
Crossref
Crossref
José A Muñoz-Gámez, Julián López Viota, Andrés Barrientos, Ángel Carazo, Laura Sanjuán-Nuñez, Rosa Quiles-Perez, Paloma Muñoz-de-Rueda, Ángel Delgado, Ángeles Ruiz-Extremera & Javier Salmerón. (2015) Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles. Liver International 35:4, pages 1430-1441.
Crossref
Crossref
Masahide MATSUDA, Tetsuya YAMAMOTO, Eiichi ISHIKAWA, Kei NAKAI, Hiroyoshi AKUTSU, Kuniyuki ONUMA & Akira MATSUMURA. (2015) Profile Analysis of Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study. Neurologia medico-chirurgica 55:9, pages 749-755.
Crossref
Crossref
Uros Smrdel, Viljem Kovac, Mara Popovic & Matjaz Zwitter. (2014) Glioblastoma patients in Slovenia from 1997 to 2008. Radiology and Oncology 48:1, pages 72-79.
Crossref
Crossref
C-H Fan, W-L Liu, H Cao, C Wen, L Chen & G Jiang. (2013) O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas. Cell Death & Disease 4:10, pages e876-e876.
Crossref
Crossref
T T Huang, J Hlavaty, D Ostertag, F L Espinoza, B Martin, H Petznek, M Rodriguez-Aguirre, C E Ibañez, N Kasahara, W Gunzburg, H E Gruber, D Pertschuk, D J Jolly & J M Robbins. (2013) Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model. Cancer Gene Therapy 20:10, pages 544-551.
Crossref
Crossref
Darshana S. Jain, Rajani B. Athawale, Amrita N. Bajaj, Shruti S. Shrikhande, Peeyush N. Goel, Yuvraj Nikam & Rajiv P. Gude. (2013) Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 Glioma cells. Biomedicine & Aging Pathology 3:4, pages 201-208.
Crossref
Crossref
A. Gutenberg, C. B. Lumenta, W. E. K. Braunsdorf, M. Sabel, H. M. Mehdorn, M. Westphal & A. Giese. (2013) The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience. Journal of Neuro-Oncology 113:2, pages 163-174.
Crossref
Crossref
Daniel Hochhauser, Rob Glynne-Jones, Vanessa Potter, Cristina Grávalos, Thomas J. Doyle, Kumudu Pathiraja, Qing Zhang, Ling Zhang & Edward A. Sausville. (2013)
A Phase II Study of Temozolomide in Patients with Advanced Aerodigestive Tract and Colorectal Cancers and Methylation of the
O
6-Methylguanine-DNA Methyltransferase Promoter
. Molecular Cancer Therapeutics 12:5, pages 809-818.
Crossref
Crossref
Ari-Nareg Meguerditchian, Sarkis H. Meterissian & Marissa Grace Ponzo. 2013. Experimental and Clinical Metastasis. Experimental and Clinical Metastasis
319
350
.
Michael D PradosSoon-Tae LeePatrick Y Wen. 2012. Advances in the Pathogenesis and Treatment of Glioblastoma Multiforme. Advances in the Pathogenesis and Treatment of Glioblastoma Multiforme
16
26
.
Pedro Pérez Segura, Miguel Gil, Carmen Balañá, Ignacio Chacón, José Muñoz Langa, María Martín & Jordi Bruna. (2012) Phase II trial of temozolomide for leptomeningeal metastases in patients with solid tumors. Journal of Neuro-Oncology 109:1, pages 137-142.
Crossref
Crossref
Sadhak Sengupta, Jaclyn Marrinan, Caroline Frishman & Prakash Sampath. (2012) Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy. Clinical and Developmental Immunology 2012, pages 1-7.
Crossref
Crossref
P. Gaviani, A. Silvani, E. Lamperti, A. Botturi, G. Simonetti, I. Milanesi, D. Ferrari & A. Salmaggi. (2011) Infections in neuro-oncology. Neurological Sciences 32:S2, pages 233-236.
Crossref
Crossref
Yu-Hui Zhang, He Zhang, Jian-min Liu & Zhi-Jian Yue. (2010) Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats. Medical Oncology 28:3, pages 901-906.
Crossref
Crossref
Lucio Tentori, Annalisa Susanna Dorio, Emanuela Mazzon, Alessia Muzi, Andrea Sau, Salvatore Cuzzocrea, Patrizia Vernole, Giorgio Federici, Anna Maria Caccuri & Grazia Graziani. (2011) The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma. European Journal of Cancer 47:8, pages 1219-1230.
Crossref
Crossref
Nathalie Wauthoz, Philippe Deleuze, Amandine Saumet, Christophe Duret, Robert Kiss & Karim Amighi. (2010) Temozolomide-Based Dry Powder Formulations for Lung Tumor-Related Inhalation Treatment. Pharmaceutical Research 28:4, pages 762-775.
Crossref
Crossref
Y. Chiba, N. Hashimoto, A. Tsuboi, Y. Oka, A. Murao, M. Kinoshita, N. Kagawa, Y. Oji, N. Hosen, S. Nishida, H. Sugiyama & T. Yoshimine. (2010) Effects of Concomitant Temozolomide and Radiation Therapies on WT1-specific T-cells in Malignant Glioma. Japanese Journal of Clinical Oncology 40:5, pages 395-403.
Crossref
Crossref
Ami Sabharwal & Mark Middleton. 2010. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
827
842
.